|Nom||Titre||Payer||Exercé||Année de naissance|
|Mr. Kevin T. Conroy||Chairman, Pres & CEO||1,51M||27,76M||1966|
|Mr. Jeffrey T. Elliott CFA||Chief Financial Officer||643,82k||S.O.||1978|
|Mr. Graham P. Lidgard||Chief Science Officer||744,93k||1,51M||1949|
|Mr. D. Scott Coward||Chief Admin. Officer, Sr. VP, Gen. Counsel & Sec.||745,27k||S.O.||1965|
|Mr. Mark Stenhouse||Pres of Cologuard||952,26k||S.O.||1967|
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
L’ISS Governance QualityScore de Exact Sciences Corporation en date du 29 juillet 2019 est 6. Les scores principaux sont Audit : 2; Société : 6; Droits des actionnaires : 8; Compensation : 7.